Tim Curtis

Professor

Phone+44 (0)28 9097 6459
Emailt.curtis@qub.ac.uk

Room 01.061 - CEM
United Kingdom

Accepting PhD Students

PhD projects

Professor Curtis is open to PhD applications from candidates with a basic science or clinical background. His areas of interest include: - Vascular Physiology - Diabetic Retinopathy - Therapeutics for Eye Disease Previous research experience is desirable although not essential.

Research output per year

If you made any changes in Pure these will be visible here soon.

5 Finished
10 Active

5 results

Filter

Finished

R2092CEM: Endothelial NOX2 NADPH oxidase as a key driver of cardiac remodelling associated with diabetes
Grieve, D., Curtis, T. & Margariti, A.
30/04/2015 → 21/12/2018
Project: Research
R1757CVS: The role of mechanosensitive TRP channels in arteriolar myogenic signalling and blood flow autoregulation
Curtis, T., McGeown, G. & Zholos, A.
01/08/2011 → 24/11/2017
Project: Research
R2830CVS: Testing for an excitatory role of Ca2+-sparks in arteriolar myogenic tone and pressure autoregulation
McGeown, G. & Curtis, T.
01/08/2011 → 30/06/2015
Project: Research
R2866CVS: Evaluation of TRPV4 channels as a therapeutic target for ocular neovascular disease
Curtis, T., McGeown, G. & Stitt, A.
01/08/2011 → 30/09/2015
Project: Research
R2828CVS: CAMKII: A Novel Therapeutic Target for Pathological Ocular Angiogenesis?
Curtis, T., McGeown, G. & Stitt, A.
01/08/2011 → 09/09/2015
Project: Research

Search results

R2092CEM: Endothelial NOX2 NADPH oxidase as a key driver of cardiac remodelling associated with diabetes

R1757CVS: The role of mechanosensitive TRP channels in arteriolar myogenic signalling and blood flow autoregulation

R2830CVS: Testing for an excitatory role of Ca2+-sparks in arteriolar myogenic tone and pressure autoregulation

R2866CVS: Evaluation of TRPV4 channels as a therapeutic target for ocular neovascular disease

R2828CVS: CAMKII: A Novel Therapeutic Target for Pathological Ocular Angiogenesis?